At a landmark two-day summit in Abuja, Africa’s fastest-growing diagnostics chain unveiled a hub-and-spoke franchise model promising a bold target of 500 Points of Care across Nigeria in next 3 years.
Nigeria is losing more than one million citizens every year — not to untreatable disease, but to a healthcare system that cannot tell patients what is wrong with them in time. That is the stark figure Shalina Diagnostics placed before an audience of pharmacists, doctors, clinic operators, and investors gathered this week in Abuja for the company’s inaugural Franchise Partners Meet.
The event, spanning two days at the nation’s capital, marked the most public and ambitious statement yet from a company that three years ago set out to do what no pan-African private operator has managed: build a standardised, affordable, technology-backed chain of diagnostic laboratories across Nigeria, and eventually across the continent.
Speaking to delegates, Shalina Diagnostics CEO Mr. Nalin Singla framed the problem in three simple facts: there are not enough labs; the premium chains that do exist are priced out of reach for the common man; and local labs lack the trust, the consistency, and the fast turnaround that patients and clinicians depend on.
“One million-plus Nigerians die every year due to lack of quality and timely testing. This is a problem the market cannot ignore.”
– Abbas Virji, MD, Shalina Healthcare
The company’s answer is a hub-and-spoke model it based on 3 pillars : Quality, Affordability, Availability. Under the model, franchise partners operate small patient-facing collection centres and labs, gathering samples which are then processed at Shalina’s central reference laboratories equipped with advanced diagnostic technology. Results are returned electronically with agreed turnaround times.
Shalina Healthcare Managing Director Mr. Abbas Virji, who first conceived the diagnostics arm after COVID-19 exposed the country’s testing deficit, told the summit that the network effect of scale is the key to making affordability sustainable. “By having more collection points and more scale, we can achieve lower prices for testing. The power of the community coming together, having one system — that is how we solve this.”
A BUSINESS CASE BUILT FOR ENTREPRENEURS
For aspiring franchise partners, the numbers Shalina presented were designed to dispel the notion that healthcare is an expensive sector to enter. A collection centre can pay back within three months and a full-service satellite lab achieves payback within six months, with the potential to scale as the network grows.
“You bring the location. We bring the lab. That is the entire model.”
- Nalin Singla, CEO, Shalina Diagnostics
A 27-YEAR LEGACY THAT COMMANDS TRUST
Shalina Diagnostics does not arrive in Nigeria as an unknown quantity. Shalina Diagnostics is a company launched by Shalina Healthcare, a group that has been manufacturing and distributing medicines across Africa for more than four decades, operating in 18 countries with 108 distribution depots on the continent. In Nigeria alone, the parent company has been present for 27 years, touching the lives of 40% Nigerians through 17,000 healthcare professionals, running a one-billion-tablet factory in Lagos, and more than 150 products registered with NAFDAC. The diagnostics business, now three years old, already has over 30 locations in 4 countries.
Ms. Opeyemi Akinyele, Managing Director of Shalina Healthcare Nigeria, told the summit that the diagnostics expansion is a natural extension of a mission the company has pursued since 1999. “We are anchored in three pillars — Quality, Affordability, Availability — and we are committed to delivering better health outcomes for every Nigerian.”
The company counts household names among its Nigerian pharmaceutical brands — Shal’Artem, Ibucap, Germol, Epiderm — and has earned the trust of the Pharmaceutical council of Nigeria and the Nigerian Medical Association, while the manufacturing facility has earned the commendation of NAFDAC & The House Committee onAIDS, TB and Malaria (ATM). That institutional credibility, the company argues, is something no start-up franchise competitor can replicate.
THE SCIENCE CASE: WHY DIAGNOSTICS CANNOT WAIT
The clinical argument for the summit was made by Dr. S.A. Sani, Associate Professor of Surgery and Consultant Surgeon at the University of Abuja Teaching Hospital, who laid out in unambiguous terms why access to diagnostics is not a luxury but a prerequisite for modern medicine. “Diagnostics affect approximately 70 percent of all healthcare decision-making,” Dr. Sani told delegates. “They guide prevention, screening, treatment, and monitoring. Without them, clinicians are flying blind.”
Article contributed by Vincent Ikuomola, a health correspondent based in Abuja
Photo: From left: Chief Operating Officer Shalina Diagnostics, Mr. Gaurav Bahl, MD Shalina Healthcare Nigeria, Opeyemi Akinyele, Global Head Commercial, Shalina Diagnostics, Jayant Rajani, Group Managing Director, Shalina Healthcare, Mr. Abbas Virji, Chief Executive Officer Shalina Diagnostics, Mr. Nalin Singla and Country Head, Shalina Diagnostics, Manoj Walia, during the day 2 of Shalina Diagnostics Franchisee meeting in Abuja Tuesday Photo